After her breast cancer recurred and metastasized, Janet Klein participated in a clinical trial for palbociclib, which has kept her disease in check for more than five years. Learn more: [ Ссылка ].
Ещё видео!
After her breast cancer recurred and metastasized, Janet Klein participated in a clinical trial for palbociclib, which has kept her disease in check for more than five years. Learn more: [ Ссылка ].